In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii

Acinetobacter baumannii is currently classified as one of six pathogens that contribute to increased patient mortality. Thus, exploratory studies navigating alternative treatment strategies are of supreme interest. Herein, we completed minimum inhibitory concentration (MIC) testing, and time-kill an...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul-Mutakabbir, Jacinda C., Yim, Juwon, Nguyen, Logan, Maassen, Philip T., Stamper, Kyle, Shiekh, Zain, Kebriaei, Razieh, Shields, Ryan K., Castanheira, Mariana, Kaye, Keith S., Rybak, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300792/
https://www.ncbi.nlm.nih.gov/pubmed/34356801
http://dx.doi.org/10.3390/antibiotics10070880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300792/
https://www.ncbi.nlm.nih.gov/pubmed/34356801
http://dx.doi.org/10.3390/antibiotics10070880

Ejemplares similares